• Fingers holding a shamrock, the symbol of Ireland, in the sky.

    EORTC, CTI, and IRROG collaboration opens new opportunities in Ireland

  • Mindact Breast Cancer

    Promising results for the ultra-low risk patient group in latest MINDACT analysis

  • Breast cancer study - Ameera-study_EORTC-Sanofi-BIG-AFT

    PRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

  • breast cancer

    Long-term results from MINDACT trial confirm importance of gene expression signature in choosing breast cancer patients who can be spared chemotherapy

  • breast cancer

    15 year follow up of EORTC 22922/10925 phase III trial shows reduction in breast cancer mortality and recurrence but does not confirm improved overall survival

  • EORTC abstracts selected at EBCC-12 Virtual Congress

  • Presentation Fatima Cardoso at ASCO 2020

    MINDACT (EORTC 10041/BIG3-04): Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients

  • EBCC 12 - Postponed

    EBCC12: Conference postponed until 30 Sept – 2 October 2020, in Barcelona Spain